U.S. Machinery Stock News

In early February 2026, Genpact reported fourth-quarter and full-year 2025 results showing higher sales and earnings versus 2024, raised its quarterly dividend to US$0.1875 per share, and completed a long-running share repurchase program totaling about US$2.39 billion since 2015. The company also issued 2026 guidance calling for at least 7% full-year revenue growth and higher earnings, underpinned by strong momentum in its fast-growing Advanced Technology Solutions and AI-focused...

Marsh & McLennan Companies recently reported fourth-quarter and full-year 2025 results showing higher sales and earnings versus the prior year, outlined plans to deploy about US$5 billion across dividends, acquisitions and buybacks in 2026, and announced leadership, product, and capital allocation updates across its Marsh and Marsh McLennan Agency businesses. Among the most interesting developments, Marsh McLennan Agency launched Secure Harbor, a specialized group captive insurer offering...

The latest move from SLB (SLB) is a US$1.5b, five year integrated contract with Kuwait Oil Company for the Mutriba field, covering design, development and production management in complex reservoir conditions. See our latest analysis for SLB. That Kuwait contract lands at a time when SLB’s short term momentum is strong, with a 12.17% 1 month share price return, a 37.36% 3 month share price return and a 26.12% year to date share price return. These contribute to a 29.34% 1 year total...

If you are wondering whether RLI is attractively priced or just fairly ordinary at its current level, this article walks through what the numbers say about its value. RLI shares recently closed at US$61.72, with returns of 5.6% over the last 7 days, 2.6% over 30 days, a 1.2% decline year to date and a 16.4% decline over the last year, alongside 3.6% and 42.5% returns over the past 3 and 5 years respectively. These mixed returns give some context for why investors may be reassessing what they...

Benchmark Electronics reported past fourth-quarter 2025 results with sales rising to US$704.33 million from US$656.89 million a year earlier, while net income and diluted EPS from continuing operations declined to US$5.97 million and US$0.17 respectively. Management also issued first-quarter 2026 guidance calling for US$655 million to US$695 million in revenue and GAAP diluted EPS of US$0.31 to US$0.37, highlighting support from strong bookings, program ramps, and capacity expansions. Next,...

e.l.f. Beauty (NYSE:ELF) is integrating the Rhode brand into its portfolio and pushing rapid global expansion, including new distribution through Sephora UK. The company is pairing this rollout with a telenovela inspired Super Bowl campaign featuring high profile celebrities and bilingual storytelling for English and Spanish speaking audiences. The marketing push highlights and celebrates the Latinx community while aiming to build broader international awareness for both e.l.f. and...

Earlier this month, Amprius Technologies announced a manufacturing partnership with Nanotech Energy to create a U.S.-based production pathway for its high-performance silicon-anode battery cells, supporting defense, aerospace, and other mission-critical customers under National Defense Authorization Act sourcing requirements. By adding Nanotech as its first American manufacturing partner and extending its “manufacturing-light” model beyond 2.00 GWh of global capacity, Amprius gains a more...

MongoDB announced new AI product integrations, including Voyage AI models, aimed at extending its platform's AI capabilities. The company is positioning these tools to support modernization of legacy applications and broaden use cases across its cloud database offerings. MongoDB, listed as NasdaqGM:MDB, sits at the center of the database and cloud services market, with a current share price of $344.35. The stock return over the past year is 23.9%, while the year to date return is a decline...

Why Fortrea Holdings (FTRE) Is Drawing Fresh Attention Fortrea Holdings (FTRE) is back on investor radars after a mixed run, including a roughly 16% month decline and a gain of about 31% over the past 3 months. The contract research group, which reported around US$2.76b in revenue and a net loss of about US$1.03b, now trades near US$14.65. This has invited closer scrutiny of its risk and return profile. See our latest analysis for Fortrea Holdings. At around US$14.65, Fortrea Holdings has...

Central Bancompany, Inc. reported past full-year 2025 results on January 27, 2026, with net interest income of US$789.67 million, net income of US$390.85 million, and diluted EPS from continuing operations of US$1.75, alongside lower fourth-quarter net charge-offs of US$2.84 million versus US$3.48 million a year earlier. The combination of higher earnings and reduced credit losses points to stronger core banking performance, indicating improved efficiency in generating income from lending...

If you have been wondering whether Sysco's share price around US$86.53 still makes sense for long term investors, this article is going to walk through what that number could imply for value. Sysco's stock has recently posted returns of 3.2% over 7 days, 16.5% over 30 days, 19.2% year to date, 25.1% over 1 year, 21.1% over 3 years and 29.2% over 5 years. This naturally raises questions about how much optimism is already reflected in the price. Recent coverage has continued to focus on...

Raymond James Financial (RJF) is back in focus after first quarter results paired revenue of US$4,176 million with softer profits, while adviser recruiting, resilient private client and asset management units, and recently completed buybacks drew investor attention. See our latest analysis for Raymond James Financial. At a share price of US$172.14, Raymond James Financial has logged a 6.31% 90 day share price return and a 4.17% 1 year total shareholder return. This suggests momentum has...

Why Astronics is on investors’ radar right now Astronics (ATRO) is back in focus after announcing preliminary, unaudited fourth quarter and full year 2025 results, while reiterating its 2026 revenue outlook of US$950 million to US$990 million. The reaffirmed guidance, which implies projected revenue growth of about 10% to 15% over 2025, gives investors a clearer anchor for evaluating the company’s order trends and end market demand. See our latest analysis for Astronics. The reaffirmed 2026...

Essex Property Trust reported past fourth-quarter 2025 results with revenue of US$479.63 million and net income of US$80.57 million, while issuing 2026 net income guidance of US$5.55–US$6.05 per diluted share. Despite lower GAAP earnings, Essex delivered strong same-property revenue and NOI growth, high occupancy around 96%, and Core FFO ahead of expectations, though 2026 Core FFO per share is projected to be flat due to structured finance headwinds. Next, we’ll examine how Essex’s flat 2026...

Recent price performance and business snapshot Illumina (ILMN) has seen pressure on its share price recently, with a 10% decline over the past day, 17% over the past week, and 15% over the past month. This has left the stock modestly lower over the past 3 months. Despite these short term moves, the company reports annual revenue of US$4,343.0 and net income of US$850.0. Its results are supported by sequencing and array based products and services used across research, clinical, and commercial...

In early February 2026, Upwork released its latest In-Demand Skills report showing rapid growth in AI-related freelance work, just as new enterprise AI automation tools were announced that aim to replace repetitive, software-driven tasks rather than simply assist workers. This combination of rising AI-enabled freelance demand and fears that automation could bypass traditional software and services platforms highlights an emerging tension between AI as a work enhancer and AI as a potential...

If you are wondering whether W. P. Carey is offering good value at its current price, you are not alone; many income focused investors are asking the same question right now. The stock recently closed at US$71.21, with returns of 2.1% over 7 days, 7.1% over 30 days, 9.8% year to date, 34.4% over 1 year, 2.8% over 3 years, and 38.0% over 5 years. Recent news coverage has focused on W. P. Carey as a large, diversified net lease REIT, often highlighting its tenant mix and focus on long term...

If you are trying to figure out whether United Airlines Holdings is attractively priced or already fully valued, the recent share performance gives you a useful starting point but not the full story. At a last close of US$115.91, the stock has returned 13.3% over the past week, 2.6% year to date and 6.3% over the last year. The 30 day return sits at a 1.2% decline, and the 3 year and 5 year returns are both very large. Recent headlines around United Airlines have focused on operational...

What recent performance tells you about Napco Security Technologies With no single headline event setting the tone, Napco Security Technologies (NSSC) has quietly drawn attention through its recent returns, including a move of 0.4% over the past day and 18.3% over the past week. See our latest analysis for Napco Security Technologies. That recent 18.3% 7 day share price return sits alongside a more measured 3.6% 30 day and 3.1% 90 day share price return, while the 1 year total shareholder...

If you are wondering whether Allison Transmission Holdings is priced attractively or looking stretched at around US$115.63, this article walks through what the numbers are saying about its current value. The stock has posted returns of 6.4% over the past 7 days, 10.9% over 30 days, 16.9% year to date, 1.0% over 1 year, 165.9% over 3 years and 195.1% over 5 years. This naturally raises questions about how much value is already reflected in the share price. Recent attention on Allison...

Why Health Canada’s Enflonsia approval matters for Merck (MRK) Merck (MRK) just picked up Health Canada approval for Enflonsia, an RSV monoclonal antibody for newborns and infants. This adds a fresh respiratory asset alongside recent earnings that highlighted ongoing demand for Keytruda. See our latest analysis for Merck. Merck’s recent Enflonsia approval lands on top of a cluster of headlines, including Q4 2025 earnings, fresh 2026 guidance, and a reaffirmed quarterly dividend. All of this...

On January 24, 2026, Tennessee officials announced a major expansion involving Centrus Energy’s Oak Ridge site, converting it into a high‑rate manufacturing plant backed by more than US$560 million of planned investment and nearly 430 new jobs in Anderson County over the coming years. This move positions Oak Ridge as a key production hub for centrifuges that Centrus plans to deploy at its Ohio enrichment operations starting in 2029, underscoring the company’s growing role in the U.S. nuclear...

Cantaloupe (CTLP) has just posted Q2 2026 results with revenue of US$78.7 million and a small net loss of US$0.07 million, translating to a near flat basic EPS of roughly US$0.00 for the quarter. The company has seen quarterly revenue move from US$73.7 million in Q2 2025 to US$78.7 million in Q2 2026, while trailing twelve month basic EPS sits at US$0.74 on net income of US$54.4 million. This sets up a picture where recent quarters look softer compared with a still profitable twelve month...

Galaxy Digital (GLXY) is back in focus after reporting a sizeable quarterly and full year net loss tied to weaker crypto prices and asset markdowns, followed quickly by a US$200 million share repurchase announcement. See our latest analysis for Galaxy Digital. The share price reaction has been sharp, with a 17.34% 1 day share price return around the buyback news, following a 37.84% 90 day share price decline. Total shareholder return over three years is very large, suggesting long term...